Devine, D P <br/><br/>
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Sep 1993 
 - 1236-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer<br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Amino Acid Sequence<br/>Analgesics--pharmacology<br/>Animals<br/>Chromatography, High Pressure Liquid<br/>Corpus Striatum--metabolism<br/>Dialysis--methods<br/>Dopamine--metabolism<br/>Enkephalin, Ala(2)-MePhe(4)-Gly(5)-<br/>Enkephalin, D-Penicillamine (2,5)-<br/>Enkephalins--pharmacology<br/>Homovanillic Acid--metabolism<br/>Hydroxyindoleacetic Acid--metabolism<br/>Limbic System--drug effects<br/>Male<br/>Microinjections<br/>Molecular Sequence Data<br/>Naltrexone--analogs & derivatives<br/>Narcotic Antagonists<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Inbred Strains<br/>Receptors, Opioid--drug effects<br/>Tegmentum Mesencephali--drug effects